Deflacort 6 mg/5 ml

Suspension

Square Pharmaceuticals PLC.

Therapeutic Class: Corticosteroid (Glucocorticoid)

6 mg Tablet

Indications

Inflammatory and allergic disorders that need a systemic corticosteroid, such as rheumatoid arthritis, asthma, severe allergic conditions, nephrotic syndrome and inflammatory skin diseases.

Pharmacology

Deflazacort is a glucocorticoid derived from prednisolone with anti-inflammatory and immunosuppressive action; 6 mg is roughly equivalent to 5 mg of prednisolone.

Dosage & Administration

Adult: usual maintenance dose 3-18 mg daily; higher doses may be needed in acute disease, as directed by the physician. Child: 0.25-1.5 mg per kg daily or on alternate days, as directed by the physician.

Side Effects

Indigestion, increased appetite, weight gain, raised blood sugar, raised blood pressure, mood changes and insomnia. Long-term use: osteoporosis, thin skin, cataract, adrenal suppression, increased risk of infection and slowed growth in children.

Precautions & Warnings

Do not stop suddenly after prolonged use; the dose must be reduced gradually. Use with caution in diabetes, hypertension, peptic ulcer, osteoporosis, glaucoma, psychiatric illness and past tuberculosis. Avoid contact with chickenpox or measles.

Contraindications

Systemic infection unless specific treatment is given, live vaccines in patients on immunosuppressive doses, and hypersensitivity to deflazacort.

Storage Conditions

Store below 30°C in a cool, dry place, away from light. Keep out of the reach of children.

This information is for reference only. Always consult a qualified doctor or pharmacist before taking any medicine.